Genetic Testing (PGT/PGD) in Indore: A Complete Clinical Guide for Fertility Patients

Preimplantation Genetic Testing (PGT) is an advanced embryology technique performed during an IVF cycle. Before an embryo is transferred to the uterus, a few cells — typically from the trophectoderm (the outer layer of a blastocyst) — are biopsied and sent to a specialist genetics laboratory. The results guide the embryologist in selecting only chromosomally normal, or 'euploid', embryos for transfer.

PGD (Preimplantation Genetic Diagnosis) is the older term and now specifically refers to testing for known single-gene disorders — conditions such as beta-thalassaemia (which carries a higher carrier prevalence in certain communities across Madhya Pradesh), cystic fibrosis, spinal muscular atrophy, or sickle cell disease. PGT-A screens all 24 chromosomes for numerical abnormalities (aneuploidy), while PGT-SR detects chromosomal structural rearrangements such as translocations carried by one or both partners.

For families in Indore, where consanguineous marriages are not uncommon and access to genetic counselling has historically been limited, PGT represents a meaningful leap forward. HomeIVF connects Indore patients with a curated network of senior embryologists and genetic counsellors who review each case before recommending the appropriate PGT variant.

Not every IVF patient requires PGT, but specific clinical profiles make it a strongly recommended addition to any cycle. The HomeIVF Medical Board identifies the following as primary indications:

Women aged 35 and above undergoing IVF benefit substantially from PGT-A because the rate of chromosomal aneuploidy in eggs rises sharply with maternal age — from roughly 20–25% at age 35 to over 50% by age 42. Couples who have experienced two or more unexplained IVF failures are also strong candidates, as undetected aneuploidy is often the silent culprit. Similarly, couples with three or more consecutive miscarriages should be evaluated for PGT-SR if either partner carries a balanced chromosomal translocation.

Families in Indore from communities with a high prevalence of haemoglobinopathies — including beta-thalassaemia — are encouraged to pursue PGD before conception. Carrier screening of both partners should ideally precede an IVF cycle. Couples where the male partner has severe oligospermia or non-obstructive azoospermia may also benefit from PGT-A, as sperm from these conditions can carry higher rates of chromosomal error. HomeIVF's intake assessment identifies candidacy within the first teleconsultation, saving patients in localities like Sudama Nagar or Rau from unnecessary travel to multiple clinics.

Understanding the procedural sequence helps patients in Indore plan their cycle timeline realistically. The process integrates seamlessly within a standard IVF cycle.

Step 1 — Ovarian Stimulation: The female partner undergoes hormonal stimulation (typically 10–14 days) to produce multiple follicles. HomeIVF's home-monitoring service allows follicle tracking via local ultrasound facilities near Vijay Nagar or Palasia, with results reviewed remotely by a senior specialist the same day.

Step 2 — Egg Retrieval and Fertilisation: Eggs are retrieved under sedation at a partner clinic and fertilised via ICSI (intracytoplasmic sperm injection), which is almost universally preferred alongside PGT to avoid contamination from residual sperm DNA.

Step 3 — Blastocyst Culture: Embryos are cultured to Day 5 or Day 6. Only those that reach blastocyst stage are eligible for biopsy. In a typical stimulation cycle, 40–60% of fertilised eggs may reach this stage.

Step 4 — Trophectoderm Biopsy: 5–8 cells are carefully removed from the outer cell layer using a laser. This does not harm the embryo's developmental potential when performed by an experienced embryologist.

Step 5 — Embryo Vitrification and Lab Analysis: Biopsied embryos are vitrified (flash-frozen) while the genetic sample is sent to an accredited laboratory. Results arrive in 10–14 working days.

Step 6 — Frozen Embryo Transfer (FET): Only euploid embryos are thawed and transferred in a subsequent cycle, maximising implantation potential.

Before entering a PGT cycle, both partners typically undergo a set of baseline investigations. These include a full karyotype (chromosomal analysis from a blood sample) for both partners, carrier screening panels relevant to ethnic and regional risk profiles, and, where indicated, sperm DNA fragmentation testing for the male partner.

For couples in Indore pursuing PGD for a specific single-gene disorder, an additional step called 'PGD probe design' or 'workup' is required. The laboratory needs a DNA sample from the affected family member (if available) and at least 6–8 weeks to design a customised genetic probe for that specific mutation. This pre-cycle workup is a critical timeline consideration patients must plan for.

Genetic counselling is non-negotiable before PGT. HomeIVF facilitates this via video consultation with credentialled genetic counsellors who can explain the difference between a 'no result' (failed biopsy analysis), a 'mosaic' embryo (containing a mixture of normal and abnormal cells), and a 'euploid' result. Mosaic embryos, in particular, require nuanced discussion — current evidence suggests carefully selected mosaic embryos can still result in healthy live births, though transfer decisions are made case by case. Patients in Indore no longer need to travel to Mumbai or Delhi for this level of specialised counselling; HomeIVF delivers it digitally.

HomeIVF is not a standalone clinic but an integrated fertility platform that coordinates the full PGT journey for patients in Indore — from initial genetic risk assessment and counselling through stimulation monitoring, cycle management, embryo biopsy, laboratory logistics, and frozen embryo transfer, all delivered through a curated network of accredited partner facilities.

For patients in Indore, HomeIVF's model means that many components of care — follicle monitoring scans, blood hormone tests (AMH, FSH, LH, oestradiol), and injection training — can be managed locally, even from neighbourhoods like Rau or Sudama Nagar, with specialist oversight provided remotely. The platform's proprietary digital dashboard allows patients to upload scan reports and receive same-day feedback from the HomeIVF Medical Board, eliminating the need for repeated visits to distant fertility centres.

HomeIVF also provides structured add-on options: endometrial receptivity testing (ERA) to optimise the FET window, sperm DNA fragmentation analysis, and comprehensive pre-implantation genetic panels. IVF packages at HomeIVF start from ₹1.5 lakh, with PGT costs outlined transparently during the initial consultation so families can plan without financial surprises. The emphasis is on evidence-based personalisation — not every couple needs every add-on, and the HomeIVF Medical Board's clinical protocols are designed to avoid unnecessary procedures.

One of the most common questions from Indore patients is: 'Does PGT actually improve my chances of having a baby?' The honest answer is nuanced. PGT-A does not increase the number of euploid embryos you produce — it identifies them. If a patient produces only one or two blastocysts, the biopsy result may show all are aneuploid, leaving no embryo available for transfer. This 'no transfer' outcome can be emotionally difficult but prevents the false hope and physical toll of a failed transfer.

However, when euploid embryos are available, the per-transfer live birth rate is significantly higher — studies report 60–70% per transfer in appropriate candidates compared to 40–55% without PGT-A selection in standard IVF. For women over 38 or those with prior recurrent loss, this improvement is clinically meaningful.

Timeline-wise, a complete PGT-IVF cycle from stimulation start to embryo transfer spans approximately 8–12 weeks when factoring in the biopsy analysis period and FET preparation. For PGD (single-gene disorder) cases requiring probe design, the total timeline extends to 4–6 months including the pre-cycle workup. HomeIVF's coordinators in Indore provide patients with a personalised cycle calendar at the outset, reducing anxiety around timeline uncertainty.

Despite Indore's growth as a medical city, several barriers continue to limit access to PGT for many couples. First, awareness remains low — many patients in localities like Palasia or Vijay Nagar are not informed by their gynaecologist that genetic testing is an option, particularly for recurrent miscarriage. Second, specialist genetic counsellors are scarce in Madhya Pradesh, often requiring travel to Pune, Mumbai, or Delhi.

Third, the cost structure of PGT at large tertiary hospitals can feel opaque — patients are quoted a base IVF price and then find genetic testing listed as a separate, significant addition without adequate explanation. Fourth, language and health literacy barriers mean many patients from semi-urban Indore or surrounding areas like Rau struggle to interpret reports without dedicated support.

HomeIVF directly addresses each of these. The platform provides Hindi-language genetic counselling support, transparent cost breakdowns during the first consultation, and a dedicated care coordinator assigned to each Indore patient for the duration of the cycle. Educational resources — including video explainers on what a 'mosaic' result means and what to expect after a negative PGT outcome — are available in the HomeIVF patient portal. By delivering senior-specialist care through a home-compatible, digitally accessible model, HomeIVF removes the geographic and informational barriers that have historically delayed genetic testing decisions for Indore families.

Receiving PGT results — whether all euploid, all aneuploid, or a combination of mosaic and normal — triggers a wide range of emotions. For couples in Indore who have already experienced miscarriage or failed cycles, the weight of these results can be profound. HomeIVF's care model integrates emotional support as a clinical priority, not an afterthought.

Patients receive results in a structured result-disclosure consultation with a HomeIVF Medical Board specialist, not via a report uploaded to a portal without context. The specialist walks through each embryo's status, explains the clinical recommendation, and allows space for questions and emotional processing. Where no euploid embryo is available, the conversation includes a compassionate discussion of next steps: a second stimulation cycle, donor egg consideration, or, in some cases, acceptance and redirection.

For couples who do proceed to frozen embryo transfer with a euploid embryo, the emotional stakes remain high. HomeIVF's follow-up protocol includes a beta-hCG blood test on Day 14 post-transfer, a viability scan at 6–7 weeks, and continued coordinator contact through the first trimester — providing the continuity of care that Indore patients often struggle to find when navigating fragmented local healthcare systems.